Your browser doesn't support javascript.
loading
Clinical evaluation of a novel microfluidic device for epitope-independent enrichment of circulating tumour cells in patients with small cell lung cancer.
Chudziak, Jakub; Burt, Deborah J; Mohan, Sumitra; Rothwell, Dominic G; Mesquita, Bárbara; Antonello, Jenny; Dalby, Suzanne; Ayub, Mahmood; Priest, Lynsey; Carter, Louise; Krebs, Matthew G; Blackhall, Fiona; Dive, Caroline; Brady, Ged.
Afiliação
  • Chudziak J; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Burt DJ; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Mohan S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Rothwell DG; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Mesquita B; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Antonello J; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Dalby S; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Ayub M; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Priest L; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Carter L; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Krebs MG; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Blackhall F; Christie NHS Foundation Trust, Manchester, UK and Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Dive C; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
  • Brady G; Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, Manchester, UK. ged.brady@cruk.manchester.ac.uk.
Analyst ; 141(2): 669-78, 2016 Jan 21.
Article em En | MEDLINE | ID: mdl-26605519
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Separação Celular / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Evaluation_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Analyst Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Separação Celular / Carcinoma de Pequenas Células do Pulmão / Neoplasias Pulmonares / Células Neoplásicas Circulantes Tipo de estudo: Evaluation_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Analyst Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido